Onaiza Cadoret-Manier
Director/Board Member chez ARDELYX, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Onaiza Cadoret-Manier is an Independent Director at Ardelyx, Inc. since 2020 and at Ventyx Biosciences, Inc. since 2023.
Previously, she held the position of Vice President-Respiratory Franchise at Genentech, Inc. from 2011 to 2018.
She also served as the Chief Commercial Officer at GRAIL LLC and Grail Biosciences from 2018 to 2019.
In addition, she was the EVP, Chief Product Strategy & Operations Officer at Ionis Pharmaceuticals, Inc. from 2020 to 2024.
Ms. Cadoret-Manier completed her undergraduate degree at Queens College in 1985 and obtained an MBA from The University of Chicago in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2024 | 35 825 ( 0,02% ) | 2 M $ | 31/03/2024 | |
ARDELYX, INC.
0,05% | 15/06/2023 | 110 150 ( 0,05% ) | 804 095 $ | 31/03/2024 |
VENTYX BIOSCIENCES, INC.
-.--% | 21/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Onaiza Cadoret-Manier
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Director/Board Member | 12/03/2020 |
| VENTYX BIOSCIENCES, INC. | Director/Board Member | 11/01/2023 |
Anciens postes connus de Onaiza Cadoret-Manier
| Sociétés | Poste | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Chief Operating Officer | 15/03/2024 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01/05/2019 |
| Grail Biosciences | Corporate Officer/Principal | 01/01/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2018 |
Formation de Onaiza Cadoret-Manier
| Queens College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
| Grail Biosciences |
